Revenue for the period slipped to 232.50 billion yen, down from 257.14 billion yen in the prior year. However, the company improved its operational efficiency, with operating profit rising to 57.91 billion yen compared to 52.07 billion yen previously. Pretax profit followed a similar upward trend, reaching 58.42 billion yen against 52.18 billion yen.
In section Market Quotes
Ono Pharmaceutical Net Profit Climbs to 44.93 Billion Yen
Ono Pharmaceutical reported a net profit of 44.93 billion yen for the six months ending September 30, marking a notable increase from the 40.09 billion yen recorded during the same period last year. Despite this bottom-line growth, the Osaka-based drugmaker faced a contraction in overall revenue for the first half.
Earnings per share climbed to 95.60 yen from 85.33 yen, with diluted earnings per share reaching 95.49 yen. These results, disclosed in accordance with IFRS accounting standards, reflect a period of mixed performance characterized by lower top-line figures offset by stronger profitability margins.
Comments (0)
No comments yet. Be the first!